136 related articles for article (PubMed ID: 2445589)
1. Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade.
Qar J; Galizzi JP; Fosset M; Lazdunski M
Eur J Pharmacol; 1987 Sep; 141(2):261-8. PubMed ID: 2445589
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.
Galizzi JP; Fosset M; Romey G; Laduron P; Lazdunski M
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7513-7. PubMed ID: 2429309
[TBL] [Abstract][Full Text] [Related]
3. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
4. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Gould RJ; Murphy KM; Reynolds IJ; Snyder SH
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5122-5. PubMed ID: 6136040
[TBL] [Abstract][Full Text] [Related]
5. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
[TBL] [Abstract][Full Text] [Related]
6. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
7. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
8. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
Homaidan FR; Donowitz M; Weiland GA; Sharp GW
Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
[TBL] [Abstract][Full Text] [Related]
9. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
10. Desmethoxyverapamil-sensitive calcium channels in rat portal vein smooth muscle.
Loirand G; Dacquet C; Pacaud P; Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
Eur J Pharmacol; 1989 Aug; 167(2):265-74. PubMed ID: 2556285
[TBL] [Abstract][Full Text] [Related]
11. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
12. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
Schmid A; Romey G; Barhanin J; Lazdunski M
Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
Galizzi JP; Fosset M; Lazdunski M
Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
[TBL] [Abstract][Full Text] [Related]
14. Identification and affinity labeling of very high affinity binding sites for the phenylalkylamine series of Ca+ channel blockers in the Drosophila nervous system.
Pauron D; Qar J; Barhanin J; Fournier D; Cuany A; Pralavorio M; Berge JB; Lazdunski M
Biochemistry; 1987 Oct; 26(20):6311-5. PubMed ID: 2827725
[TBL] [Abstract][Full Text] [Related]
15. High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations.
Ptasienski J; McMahon KK; Hosey MM
Biochem Biophys Res Commun; 1985 Jun; 129(3):910-7. PubMed ID: 2409972
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
[TBL] [Abstract][Full Text] [Related]
17. Cardiac sarcoplasmic reticulum contains a low-affinity site for phenylalkylamines.
Oeken HJ; von Nettelbladt E; Zimmer M; Flockerzi V; Ruth P; Hofmann F
Eur J Biochem; 1986 May; 156(3):661-7. PubMed ID: 3009189
[TBL] [Abstract][Full Text] [Related]
18. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.
Ferry DR; Goll A; Gadow C; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):183-7. PubMed ID: 6092974
[TBL] [Abstract][Full Text] [Related]
19. A new class of calcium entry blockers defined by 1,3-diphosphonates. Interactions of SR-7037 (belfosdil) with receptors for calcium channel ligands.
Rossier JR; Cox JA; Niesor EJ; Bentzen CL
J Biol Chem; 1989 Oct; 264(28):16598-607. PubMed ID: 2550449
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.
Striessnig J; Meusburger E; Grabner M; Knaus HG; Glossmann H; Kaiser J; Schölkens B; Becker R; Linz W; Henning R
Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):331-40. PubMed ID: 2839780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
